{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:51:07Z","timestamp":1778629867647,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008967","name":"Philipps-Universit\u00e4t Marburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008967","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>In patients with pheochromocytoma current guidelines recommend preoperative alpha-adrenoceptor blockade with selective or nonselective antagonists for at least 7\u201314\u00a0days. To date, no information exists about orally administered urapidil retard, a short-acting selective antagonist.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The medical records of consecutive patients with pheochromocytoma between 2010 and 2023 were reviewed. Patients received phenoxybenzamine between 2010 and 2017, intravenous urapidil was given between 2017 and 2019. Orally administered urapidil retard has been used from 2019 until present.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Forty-nine patients with pheochromocytomas were included. Twenty-six patients received orally administered long-acting phenoxybenzamine and 23 patients were pretreated with short-acting intravenous (n\u2009=\u20098) or orally administered urapidil (n\u2009=\u200915). Treatment prior to surgery was significantly shorter with intravenously (3\u00a0days (IQR, 3\u20134), <jats:italic>p<\/jats:italic>\u2009=\u20090.015) or orally administered urapidil (2\u00a0days (IQR 2\u20133), <jats:italic>p<\/jats:italic>\u2009=\u20090.003) compared to phenoxybenzamine (7\u00a0days (IQR, 4\u201310)). Side effects were more often in the phenoxybenzamine group (17\/26 vs 6\/23, <jats:italic>p<\/jats:italic>\u2009=\u20090.02). The modified hemodynamic instability (HI) score was low and there was no significant difference between patients treated with phenoxybenzamine and those treated with intravenous or oral urapidil (29 (IQR 18.5\u201338); 26 (IQR 18\u201342); 31 (IQR 15\u201336) ns). No 30-day postoperative mortality or cardiovascular complications occurred in any of the three groups. The postoperative hospital stay was significantly shorter in the orally administered urapidil group compared to the phenoxybenzamine group (3\u00a0days (IQR 3\u20135)) vs 4\u00a0days (IQR 4\u20135)), <jats:italic>p<\/jats:italic>\u2009=\u20090.04).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Oral pretreatment with urapidil retard is well tolerated for patients with pheochromocytoma, enabling a safe intra- and postoperative course.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00423-025-03627-6","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T21:03:26Z","timestamp":1739307806000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Short-acting urapidil compared to long-acting phenoxybenzamine in the management of pheochromocytoma"],"prefix":"10.1007","volume":"410","author":[{"given":"A.","family":"Feld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Mintziras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"W\u00e4chter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zentgraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. K.","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Czubayko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Holzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"issue":"6","key":"3627_CR1","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JWM Lenders","year":"2014","unstructured":"Lenders JWM, Duh QY, Eisenhofer G et al (2014) Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 99(6):1915\u20131942","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"3627_CR2","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/MPA.0b013e3181ebb4f0","volume":"39","author":"H Chen","year":"2010","unstructured":"Chen H, Sippel RS, Pacak K (2010) The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Pheochromocytoma. Paraganglioma Medullary Thyroid Cancer Pancreas 39(6):775\u2013783. https:\/\/doi.org\/10.1097\/MPA.0b013e3181ebb4f0","journal-title":"Paraganglioma Medullary Thyroid Cancer Pancreas"},{"issue":"8","key":"3627_CR3","first-page":"290","volume":"64","author":"AN van der Horst-Schrivers","year":"2006","unstructured":"van der Horst-Schrivers AN, Kerstens MN, Wolffenbuttel BH (2006) Preoperative pharmacological management of phaeochromocytoma. Neth J Med 64(8):290\u2013295","journal-title":"Neth J Med"},{"issue":"4","key":"3627_CR4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.4183\/aeb.2016.475","volume":"12","author":"A Reinisch","year":"2016","unstructured":"Reinisch A, Holzer K, Bojunga J et al (2016) Patients safety and feasibility of intravenous urapidil in the pretreatment of pheochromocytoma patients in a normal ward setting- an analysis of 20 consecutive cases. Acta Endocrinologica (Buc) 12(4):475\u2013480","journal-title":"Acta Endocrinologica (Buc)"},{"issue":"5","key":"3627_CR5","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00268-013-1933-9","volume":"37","author":"N Habbe","year":"2013","unstructured":"Habbe N, Ruger F, Bojunga J et al (2013) Urapidil in the preoperative treatment of pheochromocytomas: a safe and cost-effective method. World J Surg 37(5):1141\u20131146. https:\/\/doi.org\/10.1007\/s00268-013-1933-9","journal-title":"World J Surg"},{"issue":"4","key":"3627_CR6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/bja\/aeh083","volume":"92","author":"P Tauzin-Fin","year":"2004","unstructured":"Tauzin-Fin P, Sesay M, Gosse P et al (2004) Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma. Br J Anaesth 92(4):512\u2013517. https:\/\/doi.org\/10.1093\/bja\/aeh083","journal-title":"Br J Anaesth"},{"issue":"4","key":"3627_CR7","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/EJA.0000000000000941","volume":"36","author":"E Buitenwerf","year":"2019","unstructured":"Buitenwerf E, Boekel MF, van der Velde MI et al (2019) The haemodynamic instability score: Development and internal validation of a new rating method of intra-operative haemodynamic instability. Eur J Anaesthesiol 36(4):290\u2013296","journal-title":"Eur J Anaesthesiol"},{"key":"3627_CR8","unstructured":"Buitenwerf E, Buitenwerf E, Osinga TE et al (n.d.) Efficacy of phenoxybenzamine versus doxazosin on hemodynamic control during pheochromocytoma resection - a randomized controlled trial. Supplemental data. Figshare repository. https:\/\/figshare.com\/articles\/PRESCRIPT_SupplementalData_2019_pdf\/9199682.doi:10.6084\/m9.figshare.9199682. Deposited August 1, 2019."},{"issue":"4","key":"3627_CR9","first-page":"190","volume":"72","author":"PA van der Zee","year":"2014","unstructured":"van der Zee PA, de Boer A (2014) Pheochromocytoma: A review on preoperative treatment with phenoxybenzamine or doxazosin. Neth J Med 72(4):190\u2013201","journal-title":"Neth J Med"},{"issue":"2","key":"3627_CR10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/0750-7658(96)85035-0","volume":"15","author":"A Steib","year":"1996","unstructured":"Steib A, Collin F, Stojeba N et al (1996) Use of urapidil during surgery for pheochromocytoma. Ann Fr Anesth Reanim 15(2):142\u2013148. https:\/\/doi.org\/10.1016\/0750-7658(96)85035-0","journal-title":"Ann Fr Anesth Reanim"},{"issue":"1","key":"3627_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4103\/joacp.JOACP_71_18","volume":"36","author":"P Tauzin-Fin","year":"2020","unstructured":"Tauzin-Fin P, Barrucand K (2020) Sesay M et al Peri-operative management of pheochromocytoma with intravenous urapidil to prevent hemodynamic instability: A 17-year experience. J Anaesthesiol Clin Pharmacol 36(1):49\u201354. https:\/\/doi.org\/10.4103\/joacp.JOACP_71_18","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"3627_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1308\/rcsann.2023.0054","volume":"000","author":"A Bojoga","year":"2024","unstructured":"Bojoga A, Balasubramanian SP, Mihai R (2024) Surgery for phaeochromocytomas and paragangliomas: Current practice in the United Kingdom. Ann R Coll Surg Engl 000:1\u20138. https:\/\/doi.org\/10.1308\/rcsann.2023.0054","journal-title":"Ann R Coll Surg Engl"},{"issue":"1","key":"3627_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.surg.2022.05.039","volume":"173","author":"EJ Kuo","year":"2023","unstructured":"Kuo EJ, Chen L (2023) Wright JDet al: Phenoxybenzamine is no longer the standard agent used for alpha blockade before adrenalectomy for pheochromocytoma: A national study of 552 patients. Surgery 173(1):19\u201325. https:\/\/doi.org\/10.1016\/j.surg.2022.05.039","journal-title":"Surgery"},{"issue":"7","key":"3627_CR14","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1210\/clinem\/dgz188","volume":"105","author":"E Buitenwerf","year":"2020","unstructured":"Buitenwerf E, Osinga TE, Timmers LM et al (2020) Efficacy of \u03b1-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial. J Clin Endocrinol Metab 105(7):2381\u20132391. https:\/\/doi.org\/10.1210\/clinem\/dgz188","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3627_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/ijem.ijem_469_21","volume":"26","author":"SK Yadav","year":"2022","unstructured":"Yadav SK, Johri G, Jha CK et al (2022) Pre-operative selective vs non-selective \u03b1-Blockade in pheochromocytoma-paraganglioma patients undergoing surgery: a meta-analysis. Indian J Endocrinol Metab 26(1):4\u201312. https:\/\/doi.org\/10.4103\/ijem.ijem_469_21","journal-title":"Indian J Endocrinol Metab"},{"issue":"2","key":"3627_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/bja\/aew392","volume":"118","author":"H Groeben","year":"2017","unstructured":"Groeben H, Nottebaum BJ (2017) Alesina PF et al Perioperative \u03b1-receptor blockade in phaeochromocytoma surgery: an observational case series. Br J Anaesth 118(2):182\u2013189","journal-title":"Br J Anaesth"},{"issue":"2","key":"3627_CR17","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1002\/bjs.11348","volume":"107","author":"S Schimmack","year":"2020","unstructured":"Schimmack S, Kaiser J, Probst P et al (2020) Meta-analysis of \u03b1-blockade versus no blockade before adrenalectomy for phaeochromocytoma. Br J Surg 107(2):e102\u2013e108. https:\/\/doi.org\/10.1002\/bjs.11348","journal-title":"Br J Surg"},{"issue":"5","key":"3627_CR18","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1097\/JS9.0000000000000390","volume":"109","author":"J Wang","year":"2023","unstructured":"Wang J, Liu Q, Jiang S et al (2023) Preoperative \u03b1-blockade versus no blockade for pheochromocytoma-paraganglioma patients undergoing surgery: a systematic review and updated meta-analysis. Int J Surg 109(5):1470\u20131480. https:\/\/doi.org\/10.1097\/JS9.0000000000000390","journal-title":"Int J Surg"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-025-03627-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-025-03627-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-025-03627-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T21:03:28Z","timestamp":1739307808000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-025-03627-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3627"],"URL":"https:\/\/doi.org\/10.1007\/s00423-025-03627-6","relation":{},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"20 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Medical Ethical Review Committee of the Philipps-University Marburg (RS 22\/42).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"65"}}